NovMetaPharma Co., Ltd. (XKON:A229500) announced private placement series 1 non-guaranteed private convertible bonds for gross proceeds of KRW 3,000,000,000 on August 18, 2021. The transaction will involve participation from new investor Road JES Branch Private Equity Joint Venture. The bonds have a coupon rate of 0% and yield to maturity rate of 4%. The bonds will mature on August 20, 2025. The bonds are 100% convertible into 124,709 shares at a conversion price of KRW 124,709 from August 20, 2022 to August 04, 2025. The expected payment date is August 20, 2021. The transaction has been approved by the board of directors of the company.